ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Pharmaceutical effect of Murraya Koenigii on Alzheimers disease - A review

5th International Conference on Alzheimer’s Disease & Dementia

Ananya Bagchi, Dillip Kumar Swain and Analava Mitra

IIT Kharagpur, India

ScientificTracks Abstracts: J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.C1.021

Abstract
Alzheimer's disease (AD) is a disease which is being characterized by signs of major oxidative stress, the loss of cholinergic cells, depletion of Acetylcholine enzyme and the excessive activity of acetylcholinesterase enzyme.In this present review we are trying to investigate the role of the total alkaloidal extract and its predomidant carbazole alkaloid Mahanimbine from Murraya koenigii (MKA) leaves on age related oxidative stress, free radical scavenging activity and its effect in cholinergic pathway. The MKA helps to improve the level of protective antioxidants for free radicals scavenging activity such as glutathione peroxidase (GPx), reduced glutathione (GSH), glutathione such as reductase (GRD), superoxide dismutase (SOD) and catalase (CAT) in brain tissues. Interestingly a significant progress can be found with the addition of Murraya koenigii leaf extract,in improving the acetylcholine (ACh) level and reducing the acetylcholinesterase (AChE) activity in Alzheimer��?s diseased mouse brain. On the other hand in several studies it was found that a carbazole alkaloid of Murraya koenigii which is known as mahanimbine [3, 5-dimethyl-3-(4- methylpent-3-enyl)-11H-pyrano [5, 6-a] carbazole], can Inhibit AChE activity which was being proved by Ellman's method .A review on AChE inhibitory activity of this carbazole alkaloid has not been reported so far, and this review will help to study this activity of carbazole alkaloid mahanimbine, isolated from Murraya koenigii in preventing Alzheimer��?s disease.
Biography

Email: bagchiananya13@gmail.com

https://bahigox.fun/ https://bahisjet.fun/ https://bahsegel.fun/ https://betboo.fun/ https://betdoksan.xyz/ https://betebetgiris.xyz/ https://betexper.fun/ https://betgram.fun/ https://betkanyon.fun/ https://betkolik.fun/
Top